PBYI icon

Puma Biotechnology
PBYI

Overview Fund Activity

154 hedge funds and large institutions have $3.1B invested in Puma Biotechnology in 2017 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 48 increasing their positions, 48 reducing their positions, and 26 closing their positions.

Holders
154
Holders Change
+18
Holders Change %
+13.24%
% of All Funds
3.85%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.15%
New
45
Increased
48
Reduced
48
Closed
26
Calls
$130M
Puts
$125M
Net Calls
+$4.3M
Net Calls Change
+$6.02M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$300M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$162M
3
PA
3
Perceptive Advisors
New York
$64.1M
4
Millennium Management
4
Millennium Management
New York
$127M
5
PHS
5
PFM Health Sciences
California
$147M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$293M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$220M
3
RG
3
Redmile Group
California
$75.2M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$149M
5
Schroder Investment Management Group
5
Schroder Investment Management Group
United Kingdom
$32.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
176
Alambic Investment Management
California
– -$201K -5,400 Closed
JGC
177
J. Goldman & Co
New York
– -$115K -3,102 Closed
CFN
178
Cordasco Financial Network
Florida
– -$37K -1,000 Closed
QT
179
Quantbot Technologies
New York
– -$27K -748 Closed
TRCT
180
Tower Research Capital (TRC)
New York
– -$3K -91 Closed
4 5 6 7
8